Launching stakeholder discussions on identified regulatory needs for nanotechnology-enabled health products

Blanka Halamoda-Kenzaoui; Helen Box; Merel van Elk; Sandra Gaitan; Robert E. Geertsma; Eusebio Gainza Lafuente; Andrew Owen; Angel del Pozo; Matthias Roesslein; Susanne Bremer-Hoffmann

doi:10.33218/001c.13521

Loading [Contrib]/a11y/accessibility-menu.js

Halamoda-Kenzaoui, Blanka, Helen Box, Merel van Elk, Sandra Gaitan, Robert E. Geertsma, Eusebio Gainza Lafuente, Andrew Owen, Angel del Pozo, Matthias Roesslein, and Susanne Bremer-Hoffmann. 2020. “Launching Stakeholder Discussions on Identified Regulatory Needs for Nanotechnology-Enabled Health Products.” Precision Nanomedicine 3 (2): 608–21. https://doi.org/10.33218/001c.13521.

View more stats